Arcus Biosciences

RCUS54

$16.77arrow_drop_up1.69%$0.28

RCUS54

$16.77

arrow_drop_up1.69%$0.28

Performance History

Key Stats
Open	$17.04
Prev. Close	$16.49
EPS	-3.11
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-

PE Ratio	-

	LOW	HIGH
Day Range	16.64	17.31
52 Week Range	12.95	20.60

Ratios







EPS	-3.11

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Arcus Biosciences (RCUS)

Arcus Biosciences Inc (RCUS) is a biopharmaceutical company focused on developing and commercializing innovative cancer therapies. The company's mission is to harness the power of the immune system to fight cancer and improve the lives of patients. With a deep understanding of the tumor microenvironment and immune response, Arcus Biosciences is advancing a pipeline of novel immunotherapies.

One of the key factors that investors and analysts consider when evaluating a stock is its price history. The stock price history of Arcus Biosciences Inc (RCUS) can provide valuable insights into its performance over time. By analyzing the historical price data, investors can identify trends, patterns, and potential opportunities. It is important to note, however, that past performance is not necessarily indicative of future results.

Websitecall_made

Sector: Healthcare
Industry: Biotechnology
CEO: Dr. Terry J. Rosen Ph.D.
Headquarters: Hayward
Employees: 500
Exchange: NYSE

Keep an eye on Arcus Biosciences

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Arcus Biosciences 's (RCUS) price per share?

The current price per share for Arcus Biosciences (RCUS) is $16.77. The stock has seen a price change of $0.28 recently, indicating a 1.7% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Arcus Biosciences (RCUS)?

For Arcus Biosciences (RCUS), the 52-week high is $20.6, which is 22.84% from the current price. The 52-week low is $12.95, the current price is 29.5% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Arcus Biosciences (RCUS) a growth stock?

Arcus Biosciences (RCUS) has shown an average price growth of 0.41% over the past three years. It has received a score of 23 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Arcus Biosciences as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Arcus Biosciences (RCUS) stock price performance year to date (YTD)?

As of the latest data, Arcus Biosciences (RCUS) has a year-to-date price change of -14.79%. Over the past month, the stock has experienced a price change of -3.12%. Over the last three months, the change has been 4.88%. Over the past six months, the figure is -2.61%. Looking at a longer horizon, the five-year price change stands at 81.3%.

help

Is Arcus Biosciences (RCUS) a profitable company?

Arcus Biosciences (RCUS) has a net income of -$307M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 86.32% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -271.8% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $117M, with a revenue growth rate of 4.46%, providing insight into the company's sales performance and growth. The gross profit is $101M. Operating income is noted at -$340M. Furthermore, the EBITDA is -$264M.

help

What is the market capitalization of Arcus Biosciences (RCUS)?

Arcus Biosciences (RCUS) has a market capitalization of $1.51B. The average daily trading volume is 509.72K, indicating the stock's liquidity and investor engagement.